Home / Inspections / 1219094

FDA Inspection 1219094 — Otsuka Pharmaceutical Development & Commercialization, Inc

Otsuka Pharmaceutical Development & Commercialization, Inc — FEI 3000718406

The FDA completed an inspection of Otsuka Pharmaceutical Development & Commercialization, Inc on September 7, 2023 in Rockville, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 7, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Rockville, MD (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)

Facility

Other inspections at this facility

  • 1273580 (NAI Fri Jul 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1199647 (NAI Mon Feb 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1074034 (NAI Wed Nov 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1012315 (VAI Fri May 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 925330 (NAI Wed May 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources